AGO-Cervix-1 study: A prospective, randomized phase III study to compare the effects of Paclitaxel and Topotecan to those of Cisplatin and Topotecan for treatment of patients with recurrent or persistent cervical cancer

Authors :: DT Rein
M. W. Beckmann
P. A. Fasching
Ingo B. Runnebaum
Falk Thiel
Karl Ulrich Petry
Source :: Geburtshilfe und Frauenheilkunde. 68
Publication Year :: 2008
Publisher :: Georg Thieme Verlag KG, 2008.

Subjects :: Oncology
Cisplatin
Cervical cancer
medicine.medical_specialty
business.industry
Obstetrics and Gynecology
medicine.disease
chemistry.chemical_compound
medicine.anatomical_structure
Paclitaxel
chemistry
Internal medicine
Maternity and Midwifery
Medicine
Topotecan
business
Cervix
medicine.drug

Full Text Access

Tools